| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 558.22B | 577.02B | 548.13B | 510.77B | 445.32B | 405.69B |
| Gross Profit | 217.24B | 229.24B | 223.86B | 201.70B | 178.28B | 164.42B |
| EBITDA | 31.24B | 37.74B | 33.48B | 33.38B | 27.04B | 24.15B |
| Net Income | 21.51B | 29.94B | -6.71B | -13.74B | 5.38B | 7.13B |
Balance Sheet | ||||||
| Total Assets | 338.31B | 346.37B | 410.13B | 374.19B | 357.41B | 315.99B |
| Cash, Cash Equivalents and Short-Term Investments | 36.30B | 47.95B | 48.59B | 43.82B | 46.72B | 52.24B |
| Total Debt | 19.80B | 40.63B | 39.37B | 26.82B | 25.49B | 27.22B |
| Total Liabilities | 229.07B | 230.68B | 313.89B | 271.98B | 239.74B | 206.12B |
| Stockholders Equity | 102.66B | 108.09B | 88.08B | 96.24B | 112.00B | 102.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.18B | 7.00B | 6.78B | 3.19B | 2.25B |
| Operating Cash Flow | 0.00 | 24.89B | 19.41B | 15.11B | 10.04B | 9.24B |
| Investing Cash Flow | 0.00 | -9.99B | -16.14B | -12.12B | -14.18B | -9.57B |
| Financing Cash Flow | 0.00 | -5.74B | -3.62B | -8.10B | -5.50B | -4.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥36.84B | 5.10 | ― | 3.79% | -9.87% | -30.64% | |
76 Outperform | ¥148.12B | 22.89 | ― | 1.92% | 7.46% | -8.01% | |
69 Neutral | ¥4.24T | 12.61 | ― | 3.27% | 4.02% | -41.52% | |
67 Neutral | ¥635.49B | 9.47 | 6.07% | 3.69% | 0.48% | 6.92% | |
66 Neutral | ¥72.22B | 13.85 | ― | 4.01% | 0.31% | -11.70% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥159.98B | 33.83 | -6.21% | 1.61% | -4.91% | -136.94% |